Carboxymethyl cysteine is a
systemically active mucolytic agent that
achieves a high blood level concentration
after oral administration.
It acts by:
- Attaching the disulfide bonds of the thick mucous fibers to cause the complete fragmentation.
- Reducing the viscosity of the mucin secreted by the respiratory mucosa. It also protects the
mucous membrane against irritation of inhaled gases.
All cases associated with excessive viscous sputum, such as:
Patients should be expecting an increase of
Safety has not been determined during the
first trimester of pregnancy.
Dosage & route of administration & duration:
may be beneficial, followed by observation.
Treatment symptoms: GIT disturbance.
- Adults including the elderly
750 mg, 3 times daily and reduced to one capsule daily when a response is obtained.
2-5 years: 62.5-125 mg, 4 times daily.
6-12 years:250 mg, 3 times daily.
pholcodeine linctus may cause precipitation
of carbocysteine from the solution.
Gastro-intestinal symptoms such as nausea,
diarrhea or GIT (Gastro-intestinal tract
disturbance) bleeding and skin rash may
Protect from light and the temperature not exceeding 30°C.
Keep medicine out of reach of children.
Syrup: bottle of 60 and 120 ml.
Capsules: box of 20 capsules.